SEC 13F Intelligence

Managers / Q3 2020 · view latest →

Kellner Capital, LLC

CIK 0001550188 · PO BOX 1627, NEW YORK, NY, 10150 · 212-350-0262

Reported Value
$185M
Q3 2020
Positions
28
Filings on Record
20
2019–present window
Filed
Nov 9, 2020
original filing

Summary

Kellner Capital, LLC reported $185M in U.S.-listed holdings across 28 positions for Q3 2020.

Its largest position, Tiffany, represents 13.5% of the portfolio.

Compared with Q2 2020, the fund opened 15 new positions and exited 10.

Portfolio Metrics

Turnover
+51.2%
vs prior filed quarter
Top-10 Concentration
+74.5%
share of reported value
Largest Position
+13.5%
Tiffany
New / Exited
15 / 10
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q1 ’19: $147MQ1 ’19Q2 ’19: $224MQ3 ’19: $142MQ4 ’19: $158MQ4 ’19Q1 ’20: $216MQ2 ’20: $203MQ3 ’20: $185MQ3 ’20Q4 ’20: $190MQ1 ’21: $276MQ2 ’21: $326MQ2 ’21Q3 ’21: $257MQ4 ’21: $219MQ1 ’22: $134MQ1 ’22Q2 ’22: $148MQ3 ’22: $177MQ4 ’22: $86MQ4 ’22Q1 ’23: $72MQ2 ’23: $87MQ3 ’23: $85MQ3 ’23Q4 ’23: $56Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 79.1%Other: 14.0%REIT: 5.4%ADR: 1.4%Right: 0.0%
  • Common Stock · 79.1% · $146M
  • Other · 14.0% · $26M
  • REIT · 5.4% · $10M
  • ADR · 1.4% · $3M
  • Right · 0.0% · $37,000

Quarter-over-Quarter Changes full breakdown →

vs Q2 2020 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
IMMUIMMUNOMEDICS INCNEW+162.2K162.2K+$14M$14M
MNTAMOMENTA PHARMACEUTICALS INCNEW+260.3K260.3K+$14M$14M
VARIAN MED SYS INCNEW+63.1K63.1K+$11M$11M
NATIONAL GEN HLDGS CORPNEW+224.0K224.0K+$8M$8M
RSTROSETTA STONE INCNEW+244.1K244.1K+$7M$7M
LVGOLIVONGO HEALTH INCNEW+41.6K41.6K+$6M$6M
AMTTD AMERITRADE HLDG CORPNEW+133.6K133.6K+$5M$5M
AKCEA THERAPEUTICA INCNEW+194.1K194.1K+$4M$4M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2020

28 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1TIFFANY & CO NEWCOM13.51%$25M215.4K
2WTWWILLIS TOWERS WATSON PLC LTDhistory →SHS10.33%$19M91.3K
3ETRAE TRADE FINANCIAL CORPhistory →COM NEW9.89%$18M365.1K
4IMMUIMMUNOMEDICS INChistory →COM7.47%$14M162.2K
5MNTAMOMENTA PHARMACEUTICALS INChistory →COM7.39%$14M260.3K
6VARIAN MED SYS INCCOM5.87%$11M63.1K
7TCOTAUBMAN CTRS INChistory →COM5.41%$10M300.1K
8WRIGHT MED GROUP N VORD SHS5.36%$10M324.2K
9ADSWADVANCED DISP SVCS INC DELhistory →COM5.19%$10M317.4K
10NATIONAL GEN HLDGS CORPCOM4.09%$8M224.0K
11RSTROSETTA STONE INChistory →COM3.96%$7M244.1K
12LVGOLIVONGO HEALTH INChistory →COM3.15%$6M41.6K
13AMTTD AMERITRADE HLDG CORPhistory →COM2.83%$5M133.6K
14NAVNAVISTAR INTL CORPhistory →COM2.77%$5M117.5K
15AKCEA THERAPEUTICA INCCOM1.91%$4M194.1K
16HUDSON LTDCOM CL A1.71%$3M416.0K
17CLGXCORELOGIC INChistory →COM1.59%$3M43.4K
18AIMTAIMMUNE THERAPEUTICS INChistory →COM1.43%$3M76.6K
19SINA CORPORD1.30%$2M56.2K
20TCBITEXAS CAPITAL BANCSHARES INChistory →COM1.08%$2M63.9K
21DELPHI TECHNOLOGIES PLCSHS1.06%$2M117.0K
22SOGOU INCADR REPSTG A0.82%$2M171.1K
23BITAUTO HLDGS LTDSPONSORED ADS0.61%$1M72.0K
24ADIANALOG DEVICES INCcom0.54%$993,0008.5K
25CENTRAL EUROPEAN MEDIA ENTRPCL A NEW0.52%$962,000229.6K
26FITBIT INCCL A0.16%$299,00043.0K
27NOBLE ENERGY INCCOM0.03%$47,0005.5K
28BRISTOL-MYERS SQUIBB CORIGHT 99/99/99990.02%$37,00016.3K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q4 2023$56M18Feb 7, 202413F-HRchanges · EDGAR ↗
Q3 2023$85M21Nov 13, 202313F-HRchanges · EDGAR ↗
Q2 2023$87M26Aug 11, 202313F-HRchanges · EDGAR ↗
Q1 2023$72M29May 9, 202313F-HRchanges · EDGAR ↗
Q4 2022$86M33Feb 13, 202313F-HRchanges · EDGAR ↗
Q3 2022$177M41Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$148M33Aug 10, 202213F-HRchanges · EDGAR ↗
Q1 2022$134M31May 12, 202213F-HRchanges · EDGAR ↗
Q4 2021$219M28Feb 10, 202213F-HRchanges · EDGAR ↗
Q3 2021$257M27Nov 10, 202113F-HRchanges · EDGAR ↗
Q2 2021$326M31Aug 9, 202113F-HRchanges · EDGAR ↗
Q1 2021$276M33May 10, 202113F-HRchanges · EDGAR ↗
Q4 2020$190M29Feb 10, 202113F-HRchanges · EDGAR ↗
Q3 2020$185M28Nov 9, 202013F-HRchanges · EDGAR ↗
Q2 2020$203M23Aug 11, 202013F-HRchanges · EDGAR ↗
Q1 2020$216M32May 13, 202013F-HRchanges · EDGAR ↗
Q4 2019$158M31Feb 11, 202013F-HRchanges · EDGAR ↗
Q3 2019$142M27Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$224M33Aug 5, 201913F-HRchanges · EDGAR ↗
Q1 2019$147M27May 15, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 1 additional manager.

  • PRELUDE CAPITAL MANAGEMENT, LLC

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.